1. Home
  2. IMRN vs HYZN Comparison

IMRN vs HYZN Comparison

Compare IMRN & HYZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • HYZN
  • Stock Information
  • Founded
  • IMRN 1994
  • HYZN 2020
  • Country
  • IMRN Australia
  • HYZN United States
  • Employees
  • IMRN N/A
  • HYZN N/A
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • HYZN Construction/Ag Equipment/Trucks
  • Sector
  • IMRN Health Care
  • HYZN Consumer Discretionary
  • Exchange
  • IMRN Nasdaq
  • HYZN Nasdaq
  • Market Cap
  • IMRN 15.0M
  • HYZN 14.3M
  • IPO Year
  • IMRN N/A
  • HYZN N/A
  • Fundamental
  • Price
  • IMRN $1.96
  • HYZN $1.14
  • Analyst Decision
  • IMRN Strong Buy
  • HYZN Strong Buy
  • Analyst Count
  • IMRN 1
  • HYZN 1
  • Target Price
  • IMRN $5.00
  • HYZN $80.00
  • AVG Volume (30 Days)
  • IMRN 6.0K
  • HYZN 207.5K
  • Earning Date
  • IMRN 12-31-2024
  • HYZN 11-13-2024
  • Dividend Yield
  • IMRN N/A
  • HYZN N/A
  • EPS Growth
  • IMRN N/A
  • HYZN N/A
  • EPS
  • IMRN N/A
  • HYZN N/A
  • Revenue
  • IMRN $3,271,194.00
  • HYZN $10,725,000.00
  • Revenue This Year
  • IMRN N/A
  • HYZN $3,703.39
  • Revenue Next Year
  • IMRN N/A
  • HYZN N/A
  • P/E Ratio
  • IMRN N/A
  • HYZN N/A
  • Revenue Growth
  • IMRN 171.67
  • HYZN 1262.77
  • 52 Week Low
  • IMRN $1.59
  • HYZN $0.95
  • 52 Week High
  • IMRN $5.96
  • HYZN $46.00
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 45.89
  • HYZN 26.11
  • Support Level
  • IMRN $2.05
  • HYZN $1.81
  • Resistance Level
  • IMRN $2.23
  • HYZN $1.96
  • Average True Range (ATR)
  • IMRN 0.17
  • HYZN 0.14
  • MACD
  • IMRN -0.00
  • HYZN -0.04
  • Stochastic Oscillator
  • IMRN 29.69
  • HYZN 16.35

About IMRN Immuron Limited

Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

About HYZN Hyzon Motors Inc.

Hyzon Motors Inc assembles and supplies hydrogen fuel cell-powered commercial vehicles across North America, Europe, China, and Australasia. In addition, it builds and fosters a clean hydrogen supply ecosystem with partners from feedstocks through production, dispensing and financing. The company intends to meet its customers' zero-emission vehicle needs by electrifying proven vehicle platforms utilizing its industry- leading fuel cell and electric propulsion technologies. It expects to deploy these technologies in various vehicle classes, including heavy-duty and medium-duty trucks and buses with the potential for future expansion into light-duty commercial vehicles, additional mobility use cases and stationary power applications.

Share on Social Networks: